Home
About
Overview
Management Team
Board of Directors
Scientific Advisory Board
Careers
Therapeutic Areas
Fibromyalgia
Agitation in Alzheimer's Disease
Biodefense
Major Depressive Disorder
Posttraumatic Stress Disorder
Coronavirus Disease 2019 (COVID-19)
Pipeline
Overview
TNX-102 SL for Fibromyalgia
TNX-601 for Major Depressive Disorder (Depression)
TNX-601 for PTSD
TNX-102 SL for AAD
TNX-801 for Biodefense
TNX-1800 (Coronavirus Vaccine)
Scientific Presentations
Expanded Access Policy
News & Events
Press Releases
Tonix In The News
Investor Presentations
IR Events
Investors
Investor Relations
IR Overview
News / Press Releases
News / Press Releases
Press Releases
Tonix In The News
Email Alerts
Presentations & Events
Investor Presentations
IR Events
Multimedia
Multimedia
Financial Info
Financial Info
Balance Sheet
Income Statement
Cash Flow
Related Documents
Financial Results
SEC Filings
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Stock Info
Quote
Charts
Historical Data
Analyst Coverage
Governance
Governance
Board of Directors
Board Committees
Governance Documents
Contact
Multimedia
: Multimedia
Home
Investors
Multimedia
Investors
Overview
News / Press Releases
Presentations & Events
Multimedia
Financial Info
SEC Filings
Stock Info
Governance
Email Alerts
RSS News Feed
Multimedia
Videos
Tonix Pharma CEO discusses Phase 3 RALLY study results and intent to acquire new R&D facility
View Multimedia
Dr. Seth Lederman joins the Becker’s Panel to discuss the future of value in biopharma - The Becker’s Panel - June 10, 2021
View Video
Dr. Seth Lederman discusses T Cell Immunity and COVID-19 on Technology Networks
View Video
Dr. Seth Lederman interviewed by Christine Corrado of Proactive to discuss the preliminary results of its COVID-19 vaccine candidate
View Multimedia
Dr. Seth Lederman spoke to Proactive on the group's 2020 financial results and update on its second Phase 3 study of fibromyalgia.
View Multimedia
Dr. Seth Lederman interviewed by Christine Corrado of Proactive to discuss Tonix’s second collaboration with Massachusetts General Hospital
View Multimedia
Dr. Seth Lederman interviewed on ABC FOX Montana to discuss highlights of Tonix’s planned vaccine manufacturing facility in Hamilton, MT
View Multimedia
Dr. Seth Lederman interviewed by Christine Corrado of Proactive Investors to discuss the positive Phase 3 results from its fibromyalgia trial using TNX-102 SL
View Video
Dr. Seth Lederman interviewed by Christine Corrado of Proactive Investors to discuss the similarities between a circa 1860 U.S. smallpox vaccine and horsepox virus
View Video
Dr. Seth Lederman interviewed on Contagion Live to discuss its COVID-19 vaccine in development.
View Multimedia
Developing a PTSD Therapeutic - Phase 3 Clinical Development
View Video
Antibody vs. T Cell Immunity: Is a Single Vaccine Enough to Stop COVID-19
View Video
Dr. Seth Lederman presents at the Proactive One2One Virtual Event on August 18, 2020
View Multimedia
Dr. Seth Lederman presents a vaccine tutorial covering the challenges and opportunities of developing a vaccine for COVID-19
View Video
Dr. Seth Lederman interviewed by Christine Corrado of Proactive Investors to discuss strategic partnerships in developing vaccines for COVID-19
View Video
Dr. Seth Lederman interviewed on Bloomberg TV to discuss the goals & timeline for development of TNX-1800, Tonix’s live replicating COVID-19 vaccine candidate.
View Video
Seth Lederman interviewed by KWTX’s Haley Vyrostek about Tonix’s partnership with Fujifilm Diosynth to manufacture and develop their COVID-19 vaccine candidate, TNX-1800, for clinical trial supply.
View Video
MicroCap Investing Workshop: Potential Solutions for Addressing the Coronavirus Pandemic
View Video
Tonix Pharmaceuticals Discusses Developing COVID-19 Vaccine in Collaboration with Southern Research
View Video
Radio
New York City based pharmaceutical company chooses College Station to manufacture possible coronavirus vaccine
Listen Now
Efforts to Manufacture a COVID-19 Vaccine (Podcast)
Listen Now
